Innovative Smoking Cessation App with Real-Time Support Significantly Boosts Quitting Success in Clinical Trial

A new clinical trial reveals that a real-time, tailored smoking cessation app nearly doubles quit rates among low-income smokers, providing a promising tool for public health intervention.
Despite a notable decline in smoking rates across the United States over the past sixty years, tobacco use remains disproportionately high among low-income populations, contributing to ongoing health disparities. Recent research from the University of Oklahoma highlights the potential of a smartphone application that offers personalized, real-time support to aid smoking cessation efforts. The clinical trial, published in JAMA Network Open, demonstrated that users of this app nearly doubled their chances of quitting smoking compared to traditional app-based methods.
The study compared two mobile health tools: Smart-T, an adaptive app developed by OU researchers, and QuitGuide, a static application from the National Cancer Institute. Smart-T distinguishes itself by continuously assessing users' risk factors for smoking—such as cravings, stress, and environmental cues—and delivering tailored prompts throughout the day. Conversely, QuitGuide primarily provides tracking features and tips for resisting urges without personalized interaction.
Results showed that after six months, participants using Smart-T were almost twice as likely to have successfully stopped smoking compared to those using QuitGuide. Moreover, Smart-T users engaged more with the app, found it more helpful, and were more inclined to seek additional nicotine replacement therapies like patches or gum.
Lead researcher Dr. Emily Hébert emphasized that Smart-T functions as a portable tobacco cessation counselor, especially valuable for individuals facing barriers to in-person counseling, such as transportation issues or busy schedules. The trial enrolled 454 low-income smokers from across the U.S., randomly assigning them to either app. Smart-T’s innovative feature involved prompting users multiple times daily to report on their cravings, environmental influences, and mood, with the app generating personalized risk assessments and responses—ranging from breathing exercises to nicotine therapy suggestions.
The study used biochemical verification through breath carbon monoxide levels and facial recognition technology to ensure accurate tracking of smoking status, marking a pioneering approach in mobile health research. Following promising initial results, the researchers plan to test Smart-T on larger populations with longer follow-up periods.
Hébert concluded that while not suitable for everyone, low-cost, accessible smartphone interventions like Smart-T could offer an effective and convenient pathway for low-income adults to quit smoking, advancing the broader goal of inclusive tobacco cessation strategies.
Source: https://medicalxpress.com/news/2025-08-cessation-app-real-clinical-trial.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Survey Reveals Significant Variability in Older Adults' Preparations for Aging in Place
A new survey highlights the diverse approaches older adults take to prepare for aging in place, revealing significant variation in home modifications, plans, and challenges faced by seniors. Learn about current trends and barriers to aging safely at home.
Breakthrough in COVID-19 Recovery: High-Dose Vitamin B3 Targeted at Gut Microbiome Accelerates Healing
A groundbreaking clinical trial demonstrates that targeted high-dose vitamin B3 in the gut accelerates recovery in COVID-19 patients by modulating the microbiome and boosting metabolic processes.
Understanding Heat-Related Illnesses: Red Flags and Protective Measures During Extreme Temperatures
Learn about the red flags and safety measures for heat-related illnesses during extreme temperatures. Expert insights on protecting vulnerable populations and understanding the health impacts of heatwaves.
Breakthrough in Male Contraception: First Safety Results of Hormone-Free Pill
A novel hormone-free male contraceptive pill has shown promising safety results in early human trials. Using targeted chemical YCT-529, it offers a reversible, non-invasive alternative to traditional methods, potentially transforming male reproductive health options.



